UNIGE document Scientific Article
previous document  unige:88791  next document
add to browser collection

MicroRNAs in fatty liver disease

Published in Seminars in liver disease. 2015, vol. 35, no. 1, p. 12-25
Abstract Overweight and obesity, insulin resistance and diabetes, chronic alcoholism, as well as infection by specific genotypes of hepatitis C viruses are all associated with an excessive and chronic ectopic accumulation of fat in the liver (steatosis). If the underlining causes of steatosis development are not resolved, progression toward more severe liver diseases such as inflammation, fibrosis, and cirrhosis can then occur with time. These hepatic metabolic and histological disorders are commonly referred to as fatty liver disease (FLD) and result from multiple deregulated molecular mechanisms controlling hepatic homeostasis. Among these mechanisms, deregulation of a whole network of small noncoding RNAs called microRNAs (miRNAs), which regulate gene expression at a posttranscriptional level, critically contributes to the development and progression of FLD. Specific miRNAs secreted in body fluids are also emerging as useful biomarkers of FLD and therapeutic targeting of miRNAs is currently being evaluated. The authors discuss recent findings highlighting the role and complexity of miRNA regulatory networks, which critically contribute to the development of FLD. As well, the potential therapeutic perspectives for FLD that our understanding of hepatic miRNA biology offers is considered.
Keywords Biomarkers/metabolismDisease ProgressionFatty Liver/drug therapy/genetics/metabolismHumansInflammation/genetics/metabolismInsulin Resistance/geneticsLipid Metabolism/geneticsLiver/metabolismLiver Cirrhosis/genetics/metabolismMicroRNAs/genetics/metabolismMolecular Targeted Therapy
PMID: 25632931
Full text
Article (Published version) (529 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Obésité et syndrome métabolique (803)
(ISO format)
SOBOLEWSKI, Cyril et al. MicroRNAs in fatty liver disease. In: Seminars in liver disease, 2015, vol. 35, n° 1, p. 12-25. doi: 10.1055/s-0034-1397345 https://archive-ouverte.unige.ch/unige:88791

401 hits

1 download


Deposited on : 2016-11-10

Export document
Format :
Citation style :